Axogen's CEO: Rewiring Nerves at JPMorgan – Because Peripheral Bugs Crash Harder Than a Bad Deploy

Axogen, Inc. (AXGN) presented at the 44th Annual J.P. Morgan Healthcare Conference, held on January 15, 2026, at 1:30 PM EST, with President and CEO, Michael Dale, and CFO, Lindsey Hartley, in attendance. The presentation, which was followed by a 20-minute Q&A session, aimed to share Axogen's story and its purpose of restoring peripheral nerve function to improve patients' quality of life, as stated by Michael Dale, who has been leading the company for over 1.5 years. The company's work is focused on helping patients regain sensory functions, such as feeling the sun and wind, as depicted in an image shown during the presentation, which featured a mother and child riding a bike. As part of the presentation, Dale emphasized the importance of understanding the purpose of the business, which is to restore health and improve quality of life, and highlighted Axogen's role in achieving this goal. The presentation was hosted by JPMorgan, with an associate from the healthcare group introducing the Axogen team, and was attended by various stakeholders, including investors and analysts, who had the opportunity to ask questions during the Q&A session.